Seeking Alpha

Enzon Pharmaceuticals (ENZN -2.8%) hits a new 52-week low after disclosing in a regulatory...

Enzon Pharmaceuticals (ENZN -2.8%) hits a new 52-week low after disclosing in a regulatory filing late yesterday that it's reducing its workforce from 19 employees to 12. It expects to incur about $1.3M in charges related to the reduction in force, due to cash expenditures for one-time employee termination benefits and associated costs. The company expects to record the charges and complete the reduction by the end of Q1.
Comments (1)
  • Brian Harper, CFA
    , contributor
    Comments (301) | Send Message
     
    Margins and earnings will be substantially higher than in the past. The co has huge NOLs and there's potential for the sale of drugs in development.
    4 Apr 2013, 12:17 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|